Scientia Vascular
Private Company
Total funding raised: $12.5M
Overview
Scientia Vascular is an innovative neurovascular medical device company that has developed a patented microfabrication platform to manufacture next-generation guidewires and catheters. Its technology, which involves precision laser-cutting of nitinol hypotubes to create microfeatures, aims to solve historical limitations in torque control, flexibility, and support, thereby improving procedural efficiency and outcomes in treating diseases like stroke and aneurysms. The company appears to be in a commercial or early revenue stage, actively marketing its products to hospitals and physicians while continuing to grow its team. Positioned in the high-growth neurovascular intervention market, Scientia's success hinges on clinical adoption, competition with established players, and its ability to scale manufacturing and commercial operations.
Technology Platform
Proprietary microfabrication process using precision laser-cutting of nitinol hypotubes to create devices with microfeatures (rings, beams) for superior torque control, tunable flexibility, and structural integrity in neurovascular guidewires and catheters.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Scientia Vascular competes in the neurovascular access device market against major global players like Medtronic, Stryker, Johnson & Johnson, and Terumo. These competitors have extensive product lines, significant R&D budgets, and established distribution channels. Scientia's differentiation is its niche focus on advanced microfabrication technology for superior device performance.